Method of forming a nitinol stent

Patent metadata

Field	Value
Publication number	US-9849010-B2
Application number	US-201615135947-A
Country	US
Kind code	B2
Filing date	Apr 22, 2016
Priority date	Feb 23, 2012
Publication date	Dec 26, 2017
Grant date	Dec 26, 2017

Abstract

A method of a forming a hollow, drug-eluting nitinol stent includes shaping a composite wire into a stent pattern, wherein the composite wire includes an inner member, a nitinol intermediate member, and an outer member. After the composite wire is shaped into the stent pattern, the composite wire is heat treated to set the nitinol intermediate member in the stent pattern. After heat treatment, the composite wire is processed to remove the outer member and the inner member without adversely affecting the intermediate member. Openings may be provided through the intermediate member and the lumen of the intermediate member may be filled with a substance to be eluted through the openings.

First claim

What is claimed is:

1. A method of forming a stent comprising the steps of:
shaping a composite wire into a stent pattern having a defined stent lumen, wherein the composite wire comprises a co-extruded core member and an outer member, wherein the outer member is a nitinol material and the core member is a material having a stiffness that holds the nitinol member in the stent pattern prior to a heat treatment step;
setting the nitinol outer member into the stent pattern by heat treating the composite wire while the core member holds the nitinol outer member in the stent pattern, wherein the core member material alone, due to its stiffness, holds the outer member in the stent pattern;
providing openings through the outer member to a lumen of the outer member;
processing the composite wire such that the core member is removed from the outer member while preserving the outer member in the stent pattern.

2. The method of claim 1 , wherein the step of providing openings through the outer member comprises laser drilling openings through the outer member.

3. The method of claim 1 , wherein the core member comprises a material selected from the group consisting of tungsten and molybdenum, and wherein the step of processing the composite wire to remove the inner member comprises exposing the composite wire to xenon difluoride gas.

4. The method of claim 1 , further comprising the step of filling the lumen of the outer member with a biologically or pharmacologically active substance after the core member has been removed.

5. The method of claim 4 , wherein the substance is selected from the group consisting of antineoplastic, antimitotic, antiinflammatory, antiplatelet, anticoagulant, anti fibrin, antithrombin, antiproliferative, antibiotic, antioxidant, and antiallergic substances as well as combinations thereof.

6. The method of claim 1 , wherein a diameter of the core member is in the range of 0.0005 inch to 0.0095 inch.

7. The method of claim 1 , wherein an outer diameter of the outer member is in the range of 0.0025 inch to 0.010 inch.

8. The method of claim 7 , wherein the outer member has a thickness of at least 0.0005 inch.

9. The method of claim 1 , wherein the core member is more plastically deformable than the outer member.

10. The method of claim 1 , wherein the core member is tungsten.

11. The method of claim 10 , wherein the core member has an outer diameter of about 0.0050 inch.

12. The method of claim 11 , wherein the outer member has a wall thickness of about 0.0010 inch such that the outer member has an outer diameter of about 0.0070 inch.

13. A method of forming a stent comprising the steps of:
shaping a composite wire into a stent pattern having a defined stent lumen, wherein the composite wire comprises a co-extruded core member and an outer member, wherein the outer member is a nitinol material and the core member is a material having a stiffness that holds the nitinol member in the stent pattern prior to a heat treatment step;
setting the nitinol outer member into the stent pattern by heat treating the composite wire while the core member holds the nitinol outer member in the stent pattern, wherein the setting by heat treating step is performed solely with the use of the core member to hold the composite wire in the stent pattern;
providing openings through the outer member to a lumen of the outer member;
processing the composite wire such that the core member is removed from the outer member while preserving the outer member in the stent pattern.

14. The method of claim 13 , wherein the core member comprises a material selected from the group consisting of tungsten and molybdenum, and wherein the step of processing the composite wire to remove the inner member comprises exposing the composite wire to xenon difluoride gas.

15. The method of claim 13 , wherein a diameter of the core member is in the range of 0.0005 inch to 0.0095 inch.

16. The method of claim 13 , wherein an outer diameter of the outer member is in the range of 0.0025 inch to 0.010 inch.

17. The method of claim 16 , wherein the outer member has a thickness of at least 0.0005 inch.

18. The method of claim 13 , wherein the core member is more plastically deformable than the outer member.

19. The method of claim 13 , wherein the core member is tungsten.

20. The method of claim 19 , wherein the core member has an outer diameter of about 0.0050 inch.

Assignees

• Medtronic Vascular Inc

Inventors

• Thompson Dustin

Classifications

• C21D9/0068

  for particular articles not mentioned below · CPC title

• C22F1/006

  Resulting in heat recoverable alloys with a memory effect · CPC title

• A61F2210/0076

  multilayered, e.g. laminated structures · CPC title

• A61L2300/416

  Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus · CPC title

• A61F2240/001

  Designing or manufacturing processes · CPC title